Viralytics granted Australian patent for echoviruses for treatment of cancers
Viralytics has been granted an Australian patent covering the use of Echoviruses for the treatment of all cancers bearing expression of the integrin α2β1.
Sydney, May 27 A scientist in Australia has identified two new animal viruses, besides developing new tests for their detection and diagnosis.